2. Conditions for glass formation –Physical stability conditions
The instability of amorphous solids and their ability to recrystallize are a major obstacle to their practical use. Crystallization of an amorphous pharmaceutical substance may occur during the amorphization process, during storage, or during administration, when the solid is placed in a liquid biological medium. However, this ability to recrystallize varies greatly from one compound to another. Potential candidates for formulation in amorphous form are those with a low tendency to crystallize during the amorphization process, and then during storage of the amorphized compound. This applies to active ingredients, excipients and/or their combinations. Recrystallization is a complex phenomenon, the mechanism of which is a long-standing concern in materials science. Its interest is more recent in pharmaceutical science, focusing on the specific case of molecular compounds. The description and...
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!
Ongoing reading
Conditions for glass formation –Physical stability conditions